Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

NCT00998933 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: Testosterone gel 1.62%

Sponsor

Solvay Pharmaceuticals